Clinical Trials Browser

Active not recruiting × Interventional × Opdualag × Clear all

NCT05625399 2025-08-24

RELATIVITY-127

Phase 3 Active not recruiting

Melanoma

NCT06101134 2025-04-14

A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

Phase 2 Active not recruiting

Melanoma, Neoplasm Metastasis, Patient Preference